-+ 0.00%
-+ 0.00%
-+ 0.00%

Intellia Therapeutics grants Chief Medical Officer Jing L. Marantz 199,822 restricted stock units

PUBT·10/28/2026 20:07:30
Listen to the news
Intellia Therapeutics grants Chief Medical Officer Jing L. Marantz 199,822 restricted stock units
  • Intellia Therapeutics granted EVP and Chief Medical Officer Jing L. Marantz 199,822 common shares on October 26, 2026.
  • Marantz also received stock options covering 275,061 common shares, with an exercise price of $11.26.
  • The options expire October 25, 2036.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-436131), on October 28, 2026, and is solely responsible for the information contained therein.